BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹71 Cr | ₹88 Cr | ₹98 Cr | ₹105 Cr | ₹119 Cr |
What is the latest Total Debt ratio of BLISS GVS PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹105 Cr |
| Mar2021 | ₹119 Cr |
How is Total Debt of BLISS GVS PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | -19.17 | |
| Mar2024 | ₹88 Cr | -10.46 | |
| Mar2023 | ₹98 Cr | -6.56 | |
| Mar2022 | ₹105 Cr | -11.62 | |
| Mar2021 | ₹119 Cr | - | |
Compare Total Debt of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,503.8 Cr | 9.8% | 9.6% | 101.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 9.8% |
9.6% |
101.6% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses